Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study.
Banoei MM, McIntyre LA, Stewart DJ, Mei SHJ, Courtman D, Watpool I, Granton J, Marshall J, Dos Santos C, Walley KR, Schlosser K, Fergusson DA, Winston BW, On Behalf Of Canadian Critical Care Trials Group Ccctg, On Behalf Of Canadian Critical Care Translational Biology Group Ccctbg.
Banoei MM, et al. Among authors: marshall j.
Metabolites. 2023 Nov 10;13(11):1142. doi: 10.3390/metabo13111142.
Metabolites. 2023.
PMID: 37999238
Free PMC article.
As this study was not powered to detect outcome, how the treatment-induced metabolomic changes described in this study of MSC-treated septic shock patients are related to outcomes of septic shock in the short and long term will need to be explored in a larger adequately po …
As this study was not powered to detect outcome, how the treatment-induced metabolomic changes described in this study of MSC-treated septic …